Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8K Sell
452
-186
-29% -$6.7K ﹤0.01% 1798
2026
Q1
$22.6K Buy
638
+278
+77% +$11.3K ﹤0.01% 1551
2025
Q4
$14.6K Buy
360
+230
+177% +$10K ﹤0.01% 1668
2025
Q3
$6.11K Buy
130
+2
+2% +$104 ﹤0.01% 1831
2025
Q2
$6.67K Buy
128
+102
+392% +$5.6K ﹤0.01% 1739
2025
Q1
$1.57K Sell
26
-72
-73% -$4.64K ﹤0.01% 1998
2024
Q4
$6.71K Buy
98
+26
+36% +$1.81K ﹤0.01% 1603
2024
Q3
$5.18K Buy
72
+48
+200% +$3.39K ﹤0.01% 1716
2024
Q2
$1.66K Buy
24
+12
+100% +$875 ﹤0.01% 1844
2024
Q1
$961 Buy
+12
New +$1.07K ﹤0.01% 1792
2022
Q4
Sell
-242
Closed -$19K 1732
2022
Q3
$19K Buy
242
+124
+105% +$11.7K ﹤0.01% 1120
2022
Q2
$11K Sell
118
-4
-3% -$480 ﹤0.01% 1355
2022
Q1
$18K Hold
122
﹤0.01% 1282
2021
Q4
$17K Buy
+122
New +$17.3K ﹤0.01% 1312

Other funds holding CNMD

UMB Bank's CNMD Position: Q2 2026 in Review

UMB Bank reduced its CONMED (CNMD) stake by 29% in Q2 2026, selling an estimated $6.7K and leaving 452 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1798.

UMB Bank first reported a position in CNMD in Q4 2021 and has held it in 14 quarters since. The position peaked at $22.6K in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • UMB Bank held 452 shares of CONMED worth $14.8K as of Q2 2026.
  • UMB Bank sold 186 CONMED shares in Q2 2026, an estimated $6.7K.
  • CONMED made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1798 holding.
  • UMB Bank first reported a position in CONMED in Q4 2021 and has held it in 14 quarters since.
  • UMB Bank's CONMED position peaked at $22.6K in Q1 2026.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.